Biopsies are performed in order to examine the cause of a patient's symptoms or to examine various medical conditions. It can also ascertain the extent or stage of the disease that has previously been identified. One way to show how much an organ, such the liver, is swollen is by the results of a biopsy test. Determining the nature of a growth or lump on the skin or in a private area of the body can be challenging, but with the right biopsy, medical professionals can obtain valuable information about the issue. Because biopsies are so important, more sophisticated biopsy equipment is required for precise treatments. Histopathologists use bare eyes to see the tissue biopsies.
According to SPER Market Research, Europe Biopsy Devices Market Size– By Product, Application, By Guidance Technique, By End User-Regional Outlook, Competitive Strategies and Segment Forecast to 2033 ' states that the Europe biopsy devices market is estimated to reach USD 871.38 million by 2033 with a CAGR of 4.41%.
Growing inclination for less intrusive procedures, an increase in cancer incidence, and government programs for early cancer diagnosis are the main factors propelling the market's expansion in the European area. Breast, skin, and prostate cancer can all be diagnosed with a biopsy, which has been one of the main methods for diagnosing cancer problems. Additionally, the market is seeing a notable increase in demand for minimally invasive biopsy operations. It is projected that a number of various product and technology categories, including vacuum-assisted devices, needle-based biopsy guns, and biopsy guiding systems, will experience rapid expansion in the coming years.
Market growth may be hampered by high costs associated with devices and biopsy processes. The upfront and ongoing costs associated with acquiring and maintaining biopsy equipment, which can be substantial, especially in underfunded healthcare settings, impede the utilization of these devices. Medical device manufacturers may face challenges due to stringent restrictions, which could impede the release of innovative and creative biopsy equipment. Because of the large R&D expenditures necessary to meet these regulations, product costs are higher. The low accessibility of biopsy devices and processes in some parts of Europe, particularly in rural areas, may impede market expansion.
Request For Free Sample Report @ https://www.sperresearch.com/report-store/europe-biopsy-devices-market.aspx?sample=1
Impact of COVID-19 on Europe Biopsy Devices Market
The COVID-19 pandemic's limits led to a decline in the number of biopsy procedures, which had a substantial effect on the market for biopsy devices. A study titled "Impact of the COVID-19 Pandemic on Surgical Oncology in Europe: Results of a European Survey" found that out of all hospital departments, reported a decrease in the number of patients in the outpatient clinic; reported a decrease in the number of hospital beds and operating room capacity, respectively. The participants thus reported an average reduction for all types of oncological resections. Consequently, the expansion of the industry was adversely affected by the decrease in surgical procedures that occurred during the COVID-19 epidemic.
Europe Biopsy Devices Market Key Players
Market News for Biopsy Devices in Europe--For genomic profiling in blood and urine, Predicine introduced its CE-marked Predicine CARE in Europe. The liquid biopsy assay developed by the business is intended to target genes in cancer patients.With the launch of its industry-leading digital sequencing platform, Guardant Health, Inc. declared that its VHIO liquid biopsy testing facility in Barcelona will offer the first blood-based cancer testing services in Europe. .Some of the key plays are - Hologic, Becton, Dickinson and Company, and Boston Scientific Corporation.
Europe Biopsy Devices Market Segmentation:
The SPER Market Research report seeks to give market dynamics, demand, and supply forecast for the years up to 2033. This report contains statistics on product type segment growth estimates and forecasts
By Product: Based on the Product, Europe Biopsy Devices Market is segmented as; Needle-Based Biopsy Instruments, Procedure Trays, Localization Wires and Other Products.
By Application: Based on the Application, Europe Biopsy Devices Market is segmented as; Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy and Other Applications.
By Guidance Technique: Based on the Guidance Technique, Europe Biopsy Devices Market is segmented as; Mri-Guided Biopsy, Stereotactic-Guided Biopsy, Ultrasound-Guided Biopsy, Other Guidance Techniques.
By End User: Based on the End User, Europe Biopsy Devices Market is segmented as; Hospitals, Academic and Research Institutes, Diagnostic and Imaging Centres.
By Region: This research also includes data for Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, and Rest of Europe.
This study also encompasses various drivers and restraining factors of this market for the forecast period. Various growth opportunities are also discussed in the report
For More Information, refer to below link:-
Europe Biopsy Devices Market Business Opportunities
Related Reports:
Follow Us –
LinkedIn | Instagram | Facebook | Twitter
Contact Us:
Sara Lopes, Business Consultant – U.S.A.
SPER Market Research
+1-347-460-2899
English
Arabic
Français
Español
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian